Impact of Prematurity on the Optic Nerve

Sponsor
Nantes University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04067973
Collaborator
(none)
100
12

Study Details

Study Description

Brief Summary

The purpose of this protocol is to study the consequences of prematurity on the optic nerve. Indeed, the work already carried out on the subject suggests that prematurity induces suffering of the optic nerve with a loss of optical fibre, an essential element in the transmission of the visual nerve signal to the brain.

The investigators will therefore study two populations: a population of premature infants aged 5 to 10 years, and a control population of term infants.

The examinations performed are painless, non-invasive and non-irradiating. To date, there are no known adverse reactions to these tests. These examinations are a photo of the fundus (retinophotography), a pachymetry (measurement of the thickness of the non-contact cornea), an OCT RNFL (optical coherence tomography, scanner of the non-irradiating non-painful optical nerve) and the taking of the IOP (intraocular pressure).

They aim to measure the main morphological characteristics of the eye and the optic nerve.

This is a prospective observational study. The inclusion and measurements necessary for the study are made on the day of the consultation.

The expected results will provide new data on this population of premature infants, allowing for better management if a pathology involving the optic nerve were to occur at any age in these patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The prematurity of the newborn is now a major theme in medical research. Indeed, technological progress makes it possible to revive increasingly premature children. But being born premature also brings many complications, some of which are already well known (pulmonary, cardiac, digestive complications, etc....). At the ophthalmological level, the retinopathy of the premature child is an entity already well described, this retinal vascularization anomaly leads to many complications on the child's visual future. The optic nerves of premature infants are described as larger than those of normal children.

    Recently, a new ophthalmological condition has been described. This is the damage to the optic nerve of the premature baby, characterized by a loss of optical fibres, of major importance in the transmission of the visual signal to the brain.

    The aim of this study is to characterize the particularities of the optic nerve of the premature child, as there is currently very little data available on it in this context. Some studies have reported this, but with results that are not always homogeneous. For example, some studies report a lack of optic fiber in the temporal area of the optic nerve, while others find more pronounced atrophy on the nasal side, which has practical consequences in the examination and monitoring of these children.

    A better understanding of these disorders would make it possible to establish monitoring protocols for these children born with nerve fibre deficiency, especially to prevent subsequent fibre loss due to any pathology of ocular tone, the best known of which is glaucoma.

    The purpose of this prospective study is to compare the aspects of optic nerves in premature infants compared to those of optic nerves in non-premature infants. This aspect changes with age, with a progressive physiological decrease in the thickness of optic fiber within the optic nerve over time. It is therefore essential to match the two age groups to exploit this data.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Impact of Prematurity on the Morphological and Tomographic Aspect of the Papilla
    Anticipated Study Start Date :
    Sep 2, 2019
    Anticipated Primary Completion Date :
    Mar 2, 2020
    Anticipated Study Completion Date :
    Sep 2, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    patients

    Premature subjects benefit from the examinations described in the protocol, namely automated refractometry, intraocular air pressure, biometrics (with axial length and pachymetry (corneal thickness) performed by the same machine at the same time), a photo of the fundus (retinophotography) and an OCT RNFL. These examinations are necessary for the follow-up of premature children. All children examined at Nantes University Hospital benefit systematically from: automated refractometry, intraocular pressure in the air and a photo of the fundus.

    control

    controls benefit from two additional tests: RNFL OCT and biometrics. The duration of the RNFL OCT is about 2 minutes, with a total of 10 seconds per eye, the rest being computer manipulation. The biometrics take about 2 minutes to complete, with a total of 30 seconds per eye, the rest being computer manipulation. These two reviews are conducted on the same day as the initial consultation and directly following the consultation.

    Outcome Measures

    Primary Outcome Measures

    1. Compare the thickness of the optical fibres measured in OCT RNFL between premature subjects and controls. [10 minutes]

      The examinations performed are painless, non-invasive and non-irradiating. To date, there are no known adverse reactions to these tests. These examinations are a photo of the fundus (retinophotography), a pachymetry (measurement of the thickness of the non-contact cornea), an OCT RNFL (optical coherence tomography, scanner of the non-irradiating non-painful optical nerve) and the taking of the IOP (intraocular pressure). They aim to measure the main morphological characteristics of the eye and the optic nerve. We will therefore study two populations: a population of premature infants aged 5 to 10 years, and a control population of term infants.

    Secondary Outcome Measures

    1. Compare the cup/disc ratio [20 seconds]

      Compare the cup/disc ratio (optic nerve excavation, a criterion well used in the study of glaucoma) between the premature population and the control population.

    2. eye length [10 seconds]

      compare the measurement of the axial eye length (eye length) between the two populations.

    3. Intraocular tension [20 seconds]

      compare the intraocular tension (which can lead to a loss of optical fibre if too high, a criterion measured to avoid any bias induced by hypertonia on the thickness of the optical fibres) between the two populations.

    4. Pachymetry [20 seconds]

      compare pachymetry (corneal thickness, measurement that may interfere with intraocular pressure measurement) between premature born patients and controls

    5. refractive measurements [20 seconds]

      compare refractive measurements (myopia, hyperopia, astigmatism) between the two populations

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 10 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • For patients:

    • between 5 and 10 years old

    • Premature births: before 37 weeks of amenorrhea

    • To be able to benefit from the examinations necessary for the study (being able to set a target, to install correctly on the machines)

    For control:
    • Aged between 5 and 10 years old

    • Born after 37 SA

    • No known ophthalmological pathologies

    • To be able to benefit from the examinations necessary for the study (being able to set a target, to install correctly on the machines)

    Exclusion Criteria:
    • Patients who cannot benefit from the examinations (patients in wheelchairs, whose psychomotor delay prevents a good understanding of the examination and the need to set a target)

    • patient under the protection of justice.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Nantes University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nantes University Hospital
    ClinicalTrials.gov Identifier:
    NCT04067973
    Other Study ID Numbers:
    • RC19_0026
    First Posted:
    Aug 28, 2019
    Last Update Posted:
    Aug 28, 2019
    Last Verified:
    Aug 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Nantes University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 28, 2019